PUBLISHER: Grand View Research | PRODUCT CODE: 1404681
PUBLISHER: Grand View Research | PRODUCT CODE: 1404681
The global ultrasound devices market size is expected to reach USD 13.07 billion by 2030, registering a CAGR of 4.24% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to experience steady growth during the forecast period. This is attributed to several factors such as increased adoption of ultrasonography for diagnostic and therapeutic applications, rising technological advancements, as well an increase in the number of product launches by key players operating in the market.
Emerging innovations in ultrasound technology are expanding the market size. Hand-held ultrasound devices have made the technology more accessible for use in limited-resource communities globally. Furthermore, the introduction of 3D/4D ultrasound and the integration of artificial intelligence (Al) to automate time-consuming processes are expected to propel market growth during the forecast period. For instance, in July 2023, Sonosite ST was introduced by FUJIFILM Sonosite ST. It has a 21-inch touchscreen with an all-touch interface, a 10" by 7.5" image area, automated setting optimization for each exam type, and Auto Steep Needle Profiling (SNP). To support system compatibility, Sonosite ST belongs to the same family of transducers as Sonosite PX and Sonosite LX.
The growing use of ultrasound equipment for diagnostic imaging and therapy, as well as the rising prevalence of chronic and lifestyle-related illnesses are the key factors anticipating the market's growth. Ultrasound technology is used in various application areas such as cardiology, obstetrics/ gynecology, vascular, orthopedic, and general imaging. The rising prevalence of cardiac disorders is expected to boost the market globally. According to WHO, Cardiovascular diseases (CVDs) are the major cause of death globally, taking approximately 17.9 million lives each year. In addition, as per the Centers for Disease Control & Prevention, in the United States, every year about 805,000 people have a heart attack, and about 1 in 20 adults aged 20 and older has coronary artery disease (about 5%).
The market has the presence of several industry leaders such as GE Healthcare, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers AG, Mindray Medical International Limited, Samsung Medison Co., Ltd., and FUJIFILM SonoSite, Inc. These companies are adopting several strategies to withstand their market position. However, new entrants such as Butterfly Network, Clarius, EchoNous, Inc., Insightec, and Exo Imaging, Inc. are creating their footprints in point-of-care ultrasound devices with strong technological advancements and strategies. For instance, In June 2023, UltraSight and EchoNous announced a partnership that aimed to provide convenience to medical providers in performing cardiac ultrasounds and to assist patients in having more access to cardiac care. At ASE 2023, the primary convention for bringing together experts in echo, the new partnership was disclosed.